Jeremy Green

Companies

• Atara Biotherapeutics, Inc.Board member May 23, 2025 to now¹
• Shattuck Labs, Inc.Board member Oct 8, 2020 to now²
• IGM Biosciences, Inc.Board member Sep 17, 2019 to now³
• Fate TherapeuticsBoard member Aug 2, 2018 to now⁴
• Augmedix, Inc.Board member Oct 7, 2020 to Oct 4, 2024⁵
• Absci CorpBoard member Jul 21, 2021 to Jun 14, 2024⁶
• MedAvail Holdings, Inc.Board member Nov 27, 2020 to Jun 21, 2023⁷
• Science 37 Holdings, Inc.Board member Oct 8, 2021 to May 15, 2023⁸
• Fate TherapeuticsOfficer Dec 19, 2017 to Dec 19, 2017⁹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• AAbsci Corp ABSI8,253,316 shares¹⁰$70.5M at $8.54Mar 1, 2024
• SLShattuck Labs, Inc. STTK5,539,724 shares¹¹$30.2M at $5.46Dec 4, 2024
• FTFate Therapeutics FATE12,884,277 shares¹²$24.2M at $1.88Apr 20, 2026
• ABAtara Biotherapeutics, Inc. ATRA441,701 shares¹³$4.1M at $9.24May 23, 2025
• MMedAvail Holdings, Inc.53,702,312 shares¹⁴Jul 1, 2022
• IBIGM Biosciences, Inc.0 shares¹⁵Aug 14, 2025
• AAugmedix, Inc.0 shares¹⁶Oct 2, 2024
• S3Science 37 Holdings, Inc.0 shares¹⁷Mar 12, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 6, 2026Bought 400,000 shares at $17.00 of Attovia Therapeutics, Inc.¹⁸
• Aug 6, 2026Bought 200,000 shares at $17.00 of Attovia Therapeutics, Inc.¹⁸
• Aug 6, 2026Converted 782,854 shares of Attovia Therapeutics, Inc.¹⁸
• Apr 20, 2026Other 8,977,624 shares of Fate Therapeutics¹²
• Apr 20, 2026Other 8,977,624 shares of Fate Therapeutics¹²
• Aug 14, 2025Returned to company 2,964,843 shares of IGM Biosciences, Inc.¹⁵
• Dec 20, 2024Bought 397,964 shares at $1.68 of Fate Therapeutics¹⁹
• Dec 20, 2024Sold 341,633 shares at $1.68 of Fate Therapeutics¹⁹
• Dec 20, 2024Other 1,084,936 shares at $1.68 of Fate Therapeutics¹⁹
• Dec 20, 2024Other 1,084,936 shares at $1.68 of Fate Therapeutics¹⁹
• Dec 12, 2024Converted 30,110 shares of Fate Therapeutics²⁰
• Dec 11, 2024Bought 50,000 shares at $3.81 of ADC Therapeutics SA²¹
• Dec 11, 2024Bought 50,000 shares at $2.28 of ADC Therapeutics SA²¹
• Dec 11, 2024Bought 50,000 shares at $3.81 of ADC Therapeutics SA²¹
• Dec 11, 2024Bought 50,000 shares at $2.28 of ADC Therapeutics SA²¹
• Dec 4, 2024Other 1,026,888 shares at $1.25 of Shattuck Labs, Inc.¹¹
• Dec 4, 2024Other 1,026,888 shares at $1.25 of Shattuck Labs, Inc.¹¹
• Dec 4, 2024Bought 133,371 shares at $1.25 of Shattuck Labs, Inc.¹¹
• Dec 4, 2024Sold 133,371 shares at $1.25 of Shattuck Labs, Inc.¹¹
• Oct 2, 2024Returned to company 6,218,238 shares at $2.35 of Augmedix, Inc.¹⁶
• Oct 2, 2024Returned to company 9,446,146 shares at $2.35 of Augmedix, Inc.¹⁶
• Oct 2, 2024Returned to company 16,421,788 shares at $2.35 of Augmedix, Inc.¹⁶
• Sep 30, 2024Granted 1,734 shares of IGM Biosciences, Inc.²²
• Mar 29, 2024Granted 1,734 shares of IGM Biosciences, Inc.²³
• Mar 28, 2024Other 12,464 shares of IGM Biosciences, Inc.²³